Literature DB >> 2813268

Dose-ranging pharmacokinetics of zidovudine (azidothymidine) in the rat.

J D Unadkat1, J P Wang, D Pulham, R L Semmes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813268     DOI: 10.1023/a:1015954926307

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rats.

Authors:  F D Boudinot; S G Smith; E D Funderburg; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Pharmacokinetics of intravenous acyclovir, zidovudine, and acyclovir-zidovudine in pregnant rats.

Authors:  Stacy D Brown; Michael G Bartlett; Catherine A White
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.

Authors:  S Kaul; K A Dandekar
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

4.  Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.

Authors:  L W Frick; L St John; L C Taylor; G R Painter; P A Furman; D C Liotta; E S Furfine; D J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

5.  Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.

Authors:  C Yasuda; M Kato; D Kuroda; H Ohyanagi
Journal:  Jpn J Cancer Res       Date:  1997-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.